SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-016924
Filing Date
2021-02-10
Accepted
2021-02-10 06:00:57
Documents
4
Period of Report
2021-02-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216028d1_8k.htm 8-K 26405
2 EXHIBIT 1.1 tm216028d1_ex1-1.htm EX-1.1 260741
3 EXHIBIT 5.1 tm216028d1_ex5-1.htm EX-5.1 10076
4 GRAPHIC tm216028d1_ex5-1img001.jpg GRAPHIC 2218
  Complete submission text file 0001104659-21-016924.txt   301998
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 21609090
SIC: 2834 Pharmaceutical Preparations